A study on the clinico-epidemiological profile and the outcome of snake bite cases in the tertiary care hospital

Authors

  • Punam A. Gosavi Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India
  • Jugalkishore B. Jaju Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India
  • Ganesh R. Pawar Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India
  • Shrikant C. Dharmadhikari Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India
  • Vishal M. Ubale Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India
  • Sonal M. Parekar Department of Pharmacology,Government Medical College,Latur - 413 512, Maharashtra, India

Keywords:

Epidemiology, Snake-bite, Anti-snake venom, Outcome

Abstract

Background: Snake bite is a common medical emergency and an occupational hazard in India. It is also a major public health issue in rural India where farming is a major source of employment. Very few studies describe epidemiology of snake bite from India. Hence, this study was planned to collect information on various aspects of snake bite in a tertiary care hospital.

Methods: A prospective observational study of 167 patients of snake bite and unknown bite carried out from September 1, 2012 to August 31, 2013.

Results: Among a total 167 cases, majority were males (54.49%), aged between 20 and 40 years (38.92%). Most of the cases were laborers (61.67%) and farmers (17.36%). Peak incidence was observed during monsoon (64.67%). Bite mark was seen in 46.70% cases, upper extremity being common site (52.09%). Most cases were of vasculotoxic bite (65.26%) and few were of neurotoxic bite (19.76%). Major complications were respiratory failure (4.79%) and acute renal failure (1.8%). Average bite to needle time was 365 min. Bleeding & clotting time was raised in 44.03% & 35.19% cases, respectively. Average dose of anti-snake venom (ASV) required was 17.1 vials. Allergic reactions to ASV observed in 8.38% cases. Mean duration of hospital stay was 4.3 days. Recovery rate was 94.01% with three cases referred to higher center. Mortality rate was 2.39%.

Conclusions: Our study highlights various aspect of snake bite cases and tries to find out ways to improve quality of life of patients, decrease mortality and morbidity and decrease economic burden on society.

References

Halesha BR, Harshvardhan L, Lokesh AJ, Channaveerappa PK, Venkatesh KB. A study on the clinico-epidemiological profile and the outcome of snake bite. J Clin Diagn Res. 2013;7(1):122-6.

Patil VC, Patil HV, Patil A, Agrawal V. Clinical profile and outcome of envenomous snake-bite at tertiary care centre in western Maharashtra. Int J Med Public Health. 2011;1:28-38. [DOI via Crossref]

Wanje SD, Gadekar RE. Clinical profile of snake bite cases in Marathwada, India. Indian J Fundam Appl Sci ISSN. 2011;1(4):93-9.

Narvenear K. Correlation between timing of ASV administration and complications in snake bites. J Assoc Physicians India. 2006;54:717-9.

Paul V, Pratibha S, Prahlad KA. High-dose anti-snake venom versus low-dosen antisnake-venom in the treatment of poisonous snake bites - A critical study. J Assoc Physicians India. 2004;52:14-7.

Kulkarni ML, Annes S. Snake venom poisoning: experience with 633 cases. Indian Pediatr. 1994;31:1239-43.

Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Snake bite in south Asia: a review. Negl Trop Dis. 2010;4:e603. [DOI via Crossref]

Bawaskar HS, Bawaskar PH. Profile of snakebite envenoming in Western Maharashtra, India. Trans R Soc Trop Med Hyg. 2002;96:79-84. [DOI via Crossref]

Tembe VS, Sant SM, Purandare NM. A clinico-pathologic study of snakebite cases. J Postgrad Med. 1975;21:36-47.

Sawai Y, Honma M. Snakebite in India. Toxicon 1975;13:120-1. [DOI via Crossref]

Nayak KC, Jain AK, Sharda DP, Mishra SN. Profile of cardiac complications of snakebite. Indian Heart J. 1990;42(3):185-8.

Punde DP. Management of snake-bite in rural Maharashtra: a 10- year experience. Natl Med J India. 2005;18:71-5.

Hansdak SG, Lallar KS, Pokharel P, Shyangwa P, Karki P, Koirala S. A clinico- epidemiological study of snake bite in Nepal. Trop Doct. 1998;28(4):223-6.

Sharma SK, Khanal B, Pokhrel P, Khan A, Koirala S. Snakebite reappraisal of the situation in eastern Nepal. Toxicon 2003;41:285-9. [DOI via Crossref]

Sharma BD. Indian Poisonous Snakes: An Ecological and a Clinical Study. New Delhi: Anmol Publications Pvt. Ltd.; 2002.

Kularatne SAM. Common krait (Bungarus coerulus) bite in Anurad-hapura, Sri Lanka: a prospective clinical study, 1996-98. Postgrad Med J. 2002;78:276-80. [DOI via Crossref]

Seneviratne U, Dissanayake S. The neurological manifestations of snake bite in Sri Lanka. J Postgrad Med. 2002;48:275-8.

Howarth DM, Southee AS, Whytw IM. The lymphatic flow rates and the first aid in simulated peripheral snakes or in spider envenomation. Med J Aust. 1994;161:695-700.

Rahman R, Faiz MA, Selim S, Rahman B, Basher A, et al. Annual incidence of snake bite in rural Bangladesh. PLoS Negl Trop Dis. 2010;4(10):e860. [DOI via Crossref]

Ahmed SM, Nadeem A, Islam MS, Agarwal S, Singh L. A retrospective analysis on the snake victims in northern India, who were admitted to a tertiary level institute. Anaesthesiol Clin Pharmacol. 2012;28(1):45-50. [DOI via Crossref]

Downloads

Published

2017-01-02

How to Cite

Gosavi, P. A., Jaju, J. B., Pawar, G. R., Dharmadhikari, S. C., Ubale, V. M., & Parekar, S. M. (2017). A study on the clinico-epidemiological profile and the outcome of snake bite cases in the tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 3(2), 298–302. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/425

Issue

Section

Original Research Articles